Robert B. Catell, Director at BioRestorative Therapies, Inc. (BRTX), bought 5,000 shares at $2.80 ($14K) on 2018-05-09, disclosed to the SEC on 2018-05-10.
Recurring purchase ($14k) by Director following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |